Sign in

CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
270604595
Phone
781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-01-06 Bazemore Todd SEE REMARKS Grant or award +10,100
2025-01-06 Bazemore Todd SEE REMARKS Sale −1,993 $7.63 $15K
2025-01-06 Bazemore Todd SEE REMARKS Grant or award · Stock Option (right to buy) +45,200 45,200
2025-01-06 Brazzell Romulus K SEE REMARKS Grant or award +10,100 94,864
2025-01-06 Brazzell Romulus K SEE REMARKS Sale −2,446 $7.63 $19K 92,418
2025-01-06 Brazzell Romulus K SEE REMARKS Grant or award · Stock Option (right to buy) +45,200 45,200
2025-01-06 Iwicki Mark T CHIEF EXECUTIVE OFFICER Grant or award +22,100 285,855
2025-01-06 Iwicki Mark T CHIEF EXECUTIVE OFFICER Sale −5,779 $7.63 $44K 280,076
2025-01-06 Iwicki Mark T CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (right to buy) +99,500 99,500
2025-01-06 Reumuth Mary CHIEF FINANCIAL OFFICER Grant or award +10,100 70,287
2025-01-06 Reumuth Mary CHIEF FINANCIAL OFFICER Sale −1,706 $7.63 $13K 68,581
2025-01-06 Reumuth Mary CHIEF FINANCIAL OFFICER Grant or award · Stock Option (right to buy) +45,200 45,200
2024-12-30 BAKER BROS. ADVISORS LP 10% owner Purchase +30,620 $6.44 $197K 118,496
2024-12-30 BAKER BROS. ADVISORS LP 10% owner Purchase +279,939 $6.44 $1.8M 1,083,398
2024-06-26 Bazemore Todd SEE REMARKS Sale −4,653 $4.75 $22K 83,040
2024-06-26 Kharabi Darius CHIEF BUSINESS OFFICER Sale −5,158 $4.75 $25K 59,728
2024-06-26 Reumuth Mary CHIEF FINANCIAL OFFICER Sale −4,163 $4.75 $20K 60,187
2024-06-26 Iwicki Mark T CHIEF EXECUTIVE OFFICER Sale −15,168 $4.75 $72K 263,755
2024-06-26 Brazzell Romulus K SEE REMARKS Sale −5,489 $4.75 $26K 83,982
2024-06-11 Rosen Howard B Director Grant or award +1,400 13,887

Page 3 of 12 · 236 trades